Moody’s affirms OhioHealth’s ‘Aa2,’ ‘Aa2/VMIG 1’ and ‘P-1’ ratings

Moody’s Investors Service has affirmed the “Aa2,” “Aa2/VMIG 1” and “P-1” ratings on Columbus-based OhioHealth’s $1.05 billion of outstanding debt.

Advertisement

The “Aa2” rating affirmation is based on several factors, including OhioHealth’s history of consistently strong cash flow margins, leading market position and solid unrestricted debt position.

The “VMIG 1” and “P-1” rating assignments reflect OhioHealth’s ability to pay un-remarketed tenders and maturing commercial payer with internal liquidity.

The outlook is stable, reflecting Moody’s Investors Service’s expectations that OhioHealth will maintain its operating cash flow margins and liquidity.

More articles on healthcare finance:
Fitch affirms Denver Health’s ‘BBB+’ rating
Americans break retirement record for first time since Medicare was enacted
Republican ACA replacement plan would include changes to Medicare, taxes on premiums

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.